RESUMEN
Gentamicin is a potent broad-spectrum aminoglycoside antibiotic whose use is hampered by ototoxic side-effects. Hospital gentamicin is a mixture of five gentamicin C-subtypes and several impurities of various ranges of nonexact concentrations. We developed a purification strategy enabling assaying of individual C-subtypes and impurities for ototoxicity and antimicrobial activity. We found that C-subtypes displayed broad and potent in vitro antimicrobial activities comparable to the hospital gentamicin mixture. In contrast, they showed different degrees of ototoxicity in cochlear explants, with gentamicin C2b being the least and gentamicin C2 the most ototoxic. Structure-activity relationships identified sites in the C4'-C6' region on ring I that reduced ototoxicity while preserving antimicrobial activity, thus identifying targets for future drug design and mechanisms for hair cell toxicity. Structure-activity relationship data suggested and electrophysiological data showed that the C-subtypes both bind and permeate the hair cell mechanotransducer channel, with the stronger the binding the less ototoxic the compound. Finally, both individual and reformulated mixtures of C-subtypes demonstrated decreased ototoxicity while maintaining antimicrobial activity, thereby serving as a proof-of-concept of drug reformulation to minimizing ototoxicity of gentamicin in patients.
Asunto(s)
Antibacterianos/farmacología , Cóclea/efectos de los fármacos , Gentamicinas/efectos adversos , Gentamicinas/química , Gentamicinas/farmacología , Animales , Antibacterianos/efectos adversos , Antibacterianos/química , Antibacterianos/aislamiento & purificación , Cóclea/citología , Contaminación de Medicamentos , Gentamicinas/aislamiento & purificación , Células Ciliadas Auditivas/efectos de los fármacos , Hospitales , Canales Iónicos/metabolismo , Mecanotransducción Celular/efectos de los fármacos , Pruebas de Sensibilidad Microbiana , Ratas Sprague-Dawley , Sisomicina/farmacología , Relación Estructura-ActividadRESUMEN
Gentamicin has proven to be a very successful treatment for bacterial infection, but it also can cause adverse effects, especially ototoxicity, which is irreversible. Therapeutic drug monitoring (TDM) in saliva is a more convenient non-invasive alternative compared to plasma. A physiologically-based pharmacokinetic (PBPK) model of gentamicin was built and validated using previously-published plasma and saliva data. The validated model was then used to predict experimentally-observed plasma and saliva gentamicin TDM data in Jordanian pediatric preterm infant patients measured using sensitive LCMS/MS method. A correlation was established between plasma and saliva exposures. The developed PBPK model predicted previously reported gentamicin levels in plasma, saliva and those observed in the current study. A good correlation was found between plasma and saliva exposures. The PBPK model predicted that gentamicin in saliva is 5-7 times that in plasma, which is in agreement with observed results. Saliva can be used as an alternative for TDM of gentamicin in preterm infant patients. Exposure to gentamicin in plasma and saliva can reliably be predicted using the developed PBPK model in patients.
Asunto(s)
Infecciones Bacterianas/tratamiento farmacológico , Monitoreo de Drogas/métodos , Gentamicinas/farmacocinética , Modelos Biológicos , Ototoxicidad/prevención & control , Infecciones Bacterianas/sangre , Cromatografía Líquida de Alta Presión/instrumentación , Cromatografía Líquida de Alta Presión/métodos , Relación Dosis-Respuesta a Droga , Cálculo de Dosificación de Drogas , Monitoreo de Drogas/instrumentación , Femenino , Gentamicinas/administración & dosificación , Gentamicinas/efectos adversos , Gentamicinas/aislamiento & purificación , Humanos , Recién Nacido de Bajo Peso , Recién Nacido , Recien Nacido Prematuro , Jordania , Límite de Detección , Masculino , Ototoxicidad/sangre , Ototoxicidad/etiología , Plasma/química , Saliva/química , Eliminación Salival/fisiología , Espectrometría de Masas en Tándem/instrumentación , Espectrometría de Masas en Tándem/métodosRESUMEN
Se evaluó la actividad sinérgica de los alcaloides crotsparina y esparsiflorina, aislados de Croton bomplandianum Baill. con los antibacterianos gentamicina y ciprofloxacina frente a Pseudomonas aeruginosa, microorganismo frecuentemente responsable de infecciones intrahospitalarias. Se empleó el método del "tablero de damas". Se encontraron combinaciones que presentaban efecto sinérgico, logrando la reducción de 87,5% de la CMI de gentamicina, mientras que para ciprofloxacina se logró una reducción del 25,0%. Esto abre interesantes perspectivas sobre el uso combinado de productos naturales puros y fármacos en uso clínico para el tratamiento de infecciones producidas por este microrganismo(AU)
Asunto(s)
Pseudomonas aeruginosa/efectos de los fármacos , Gentamicinas/farmacología , Ciprofloxacina/farmacología , Croton , Alcaloides/farmacología , Antibacterianos/farmacología , Gentamicinas/aislamiento & purificación , Sinergismo Farmacológico , Alcaloides/químicaRESUMEN
We developed a Complementary Metal-Oxide-Semiconductor Bio-Microelectromechanical Systems (CMOS-BioMEMS) based piezoresistive microcantilever sensor for detecting gentamicin, a peritonitis therapeutic small-molecule drug. In recent years, the patient-centric concept has been emphasized. In such a trend, therapeutic drug monitoring (TDM) is especially crucial for patients with peritonitis to avoid adverse reactions from a high concentration of gentamicin in the blood. With the aid of a commercialized semiconductor manufacturing process, the microcantilever sensing platform can serve as a portable, low-cost device and offer real-time detection. With chemical surface modification and capture antibody immobilization, the sensor can detect the small-molecule (< 2â¯kDa) gentamicin directly. We also modified the pH value of the buffer solution and applied an external electric field to promote sensor sensitivity. Comparing the change of the signals in a non-electric field of antibody immobilization and a 60-volt electric field of antibody immobilization showed that the average signal response increased 1.8 times. In the detection of gentamicin with different concentrations of 10-200⯵g/mL, the limit of detection (LOD) of the sensor was 9.44⯵g/mL. Finally, the detecting result of a microrcantilever sensor was compared with the one measured by a common instrument in hospital, and the high correlation was expressed between them in gentamicin detection. The CMOS-BioMEMS-based piezoresistive microcantilever sensor has been demonstrated to have great potential as a point-of-care (POC) device for real-time drug concentration monitoring.
Asunto(s)
Técnicas Biosensibles , Monitoreo de Drogas , Gentamicinas/aislamiento & purificación , Peritonitis/tratamiento farmacológico , Gentamicinas/química , Humanos , Sistemas Microelectromecánicos , Óxidos/química , SemiconductoresRESUMEN
In this work, an HPLC/MS/MS method for determination of gentamicin C components in fish tissues was developed based on strong cation exchange solid-phase extraction (SPE) purification coupled with Hypercarb chromatographic column in separation mode. Sample was extracted using trichloroacetic acid aqueous solution containing EDTA. Ion-pairing reagents were not needed because of the "graphite polarity retention effect" of the Hypercarb chromatographic column. HPLC-MS/MS was performed in multiple reaction monitoring (MRM) mode for simultaneous qualitative and quantitative analyses (using matrix external standard) of gentamicin C components in fish tissues. Good linearity was obtained for the target analytes within the concentration range from 0.0100 to 0.500â¯mg/L. The limits of quantification (LOQ) of this method were 10.0, 20.0, and 20.0⯵g/kg for C1, C1a, and sum of C2â¯+â¯C2a, respectively. The average recoveries of gentamicin C components were 80.0%-110% when spiked at three levels with the blank carp (Cyprinus carpio) matrix, and the relative standard deviations (RSD) were all less than 15% (nâ¯=â¯6). In addition, for the features of simple operation, high sensitivity and good reproducibility, the proposed method has been successfully applied for detection of gentamicin residues in fish tissues during actual breeding.
Asunto(s)
Carpas , Cromatografía Líquida de Alta Presión/métodos , Residuos de Medicamentos/análisis , Gentamicinas/análisis , Carne/análisis , Animales , Residuos de Medicamentos/química , Residuos de Medicamentos/aislamiento & purificación , Gentamicinas/química , Gentamicinas/aislamiento & purificación , Límite de Detección , Modelos Lineales , Reproducibilidad de los Resultados , Extracción en Fase Sólida/métodos , Espectrometría de Masas en Tándem/métodosRESUMEN
La endocarditis infecciosa es una entidad poco frecuente durante el embarazo, pero potencialmente mortal para el feto y la madre. Presentamos el caso de una mujer de 26 años con antecedente de fiebre reumática en la infancia, diagnosticada de endocarditis estreptocócica en la semana 28 de gestación. La ecocardiografía mostraba una vegetación móvil de 20 mm en el velo posterior de la válvula mitral, que condicionaba una insuficiencia mitral severa. Respondió favorablemente al tratamiento antibiótico por vía intravenosa durante 5 semanas, sin repercusión alguna sobre el feto. Como complicación intercurrente, en el curso clínico presentó un aneurisma micótico femoral izquierdo a las 33 semanas de gestación, que fue intervenido previa maduración pulmonar fetal. El caso de esta paciente demuestra la importancia del manejo multidisciplinar de esta patología, que consiguió llevar una gestación a término consiguiendo un recién nacido y madre sanos (AU)
Infective endocarditis is a rare complication of pregnancy with high maternal and fetal mortality. We report the case of a 26-year-old woman with acute bacterial endocarditis of a rheumatic mitral valve in the 28th week of pregnancy. Echocardiography revealed a mobile vegetation of 20 mm length on the posterior leaflet of the mitral valve with subsequent severe mitral regurgitation. The patient responded favorably to a 5-week course of antibiotic therapy, and there were no signs of fetal repercussions. As an intercurrent complication, she was diagnosed with a mycotic aneurism of the femoral artery in the 33rd week of pregnancy. Antenatal corticosteroids for fetal lung maturation were administered, followed by surgery. This case illustrates the importance of a multidisciplinary approach, which, in our patient, allowed term delivery with favorable maternal and fetal outcomes (AU)
Asunto(s)
Adulto , Femenino , Humanos , Embarazo , Endocarditis/complicaciones , Endocarditis/diagnóstico , Válvula Mitral , Válvula Mitral , Antibacterianos/uso terapéutico , Aneurisma/complicaciones , Aneurisma/diagnóstico , Estreptococos Viridans/aislamiento & purificación , Diagnóstico Precoz , Endocarditis/fisiopatología , Endocarditis , Ecocardiografía/instrumentación , Ecocardiografía/métodos , /métodos , Ampicilina/uso terapéutico , Gentamicinas/aislamiento & purificación , Gentamicinas/uso terapéuticoRESUMEN
Pathogenic microorganisms can reside transiently or permanently in the gallbladder of cattle. Thus, during slaughter, more attention should be given to the gastrointestinal tract, especially to the accessory organ, the gallbladder. The main aim of this study was to characterize the bacterial microbiota present in bile and gallbladder epithelium of cattle slaughtered in a slaughtering plant under sanitary conditions and to evaluate the antimicrobial resistance in strains of the genus Staphylococcus. Thirty intact gallbladders were collected and the in bile and epithelium were researched for the presence of Aerobic Mesophilic Heterotrophic Bacteria (AMHB), Staphylococcus spp., total Enterobacteriaceae, Enterococcus spp. and Salmonella spp.The frequency of isolation of the microorganism mentioned above were, respectively: 23.02 percent, 14.39 percent, 13.67 percent, 24.46 percent, 0 percent and 24.46 percent. Concerning both gallbladder environments, the frequency of isolation of the microorganisms in the epithelium was 64.03 percent, and in the bile 35.97 percent, with no statistical difference, but with significant difference between the population averages. In antimicrobial susceptibility testing, strains of Staphylococcus from both bile and gallbladder epithelium showed sensitivity to the antimicrobials: penicillin G, ceftriaxone, chloramphenicol and gentamicin. The observation that the gallbladder supports a high frequency of microorganisms brings us to the possible fact that cattle might be a persistent carrier of pathogens of great importance to public health...
Microrganismos patogênicos podem residir temporariamente ou permanentemente na vesícula biliar de bovinos. Assim, durante o abate, maior atenção deve ser dada ao trato gastrointestinal, especialmente para o órgão acessório, a vesícula biliar. O principal objetivo deste estudo foi caracterizar a microbiota bacteriana presente na bile e no epitélio de vesículas biliares de bovinos abatidos em matadouro frigorífico sob inspeção sanitária e avaliar a resistência antimicrobiana de estirpes do gênero Staphyloccocus. Foram coletadas 30 vesículas biliares íntegras e foi pesquisada na bile e no epitélio do órgão a presença de bactérias heterotróficas aeróbias mesófilas (BHAM), Staphylococcus spp. e Enterobacteriaceae totais, Escherichia coli, Enterococcus spp. e Salmonella spp. A frequência de isolamento dos microrganismos citados acima foi, respectivamente: 23,02 por cento, 14,39 por cento, 13,67 por cento, 24,46 por cento, 0por cento e 24,46 por cento. Em relação aos dois ambientes da vesícula, a frequência de isolamento dos microrganismos no epitélio foi de 64,03 por cento, e na bile 35,97 por cento, não sendo diferente estatisticamente, mas com diferença significativa entre as médias populacionais.No teste de susceptibilidade aos antimicrobianos, as estirpes de Staphylococcus isoladas a partir da bile e do epitélio da vesícula biliar apresentaram sensibilidade a: penicilina G, ceftriaxona, cloranfenicol e gentamicina. A observação de que a vesícula biliar comporta microrganismos em elevadas frequências atenta para o fato de que o bovino possa ser um portador persistente de patógenos de grande importância em saúde pública...
Asunto(s)
Animales , Bovinos , Bovinos/microbiología , Enterobacteriaceae/aislamiento & purificación , Enterococcus/aislamiento & purificación , Escherichia coli/aislamiento & purificación , Microbiota , Salmonella/aislamiento & purificación , Staphylococcus/aislamiento & purificación , Vesícula Biliar/microbiología , Antibacterianos/aislamiento & purificación , Ceftriaxona/aislamiento & purificación , Cloranfenicol/aislamiento & purificación , Gentamicinas/aislamiento & purificación , Penicilina G/aislamiento & purificación , Noxas/aislamiento & purificaciónRESUMEN
Etimicin intermediate 3,2â³,6â³-N,N,N-triacetyl gentamicin C1a (P1), is a key intermediate of etimicin, which is a semi-synthetic aminoglycoside antibiotic effective to both gram-positive and gram-negative bacteria infections. Four major related impurities of P1 were detected by HPLC-ELSD and ESI-MS(n) methods. Weakly acidic cation exchange resin, CM-sephadex and silica gel column chromatography were used for the isolation and purification of four major impurities. By means of ESI-MS(n) and NMR analysis, related impurities were characterized as 3,2â³-N,N-diacetyl gentamicin C1a (1), 3,2â³,6â³-N,N,N-triacetyl gentamicin C2b (2), 2â³-N-acetyl gentamicin C1a (3), and 2â³,6â³-N,N-diacetyl gentamicin C1a (4). Impurities 1, 2, 4 are novel compounds and the NMR data of these isolates were first reported in this paper. The possible mechanism for the formation of these impurities is also discussed.
Asunto(s)
Aminoglicósidos/síntesis química , Contaminación de Medicamentos , Gentamicinas/química , Gentamicinas/aislamiento & purificación , Aminoglicósidos/química , Cromatografía Liquida , Espectroscopía de Resonancia Magnética , Estructura Molecular , Espectrometría de Masa por Ionización de ElectrosprayRESUMEN
Electrochemical degradation of gentamicin was achieved using a laboratory scale electrochemical reactor by optimizing pH, current density and treatment time. A two step statistical optimization was performed as per factorial design and center composite design (CCD). A Pareto chart was used for selecting statistically significant effects and an analysis of variance (ANOVA) table indicated significant curvature. Thus adding additional experimental runs improved the model fitting through a second order model. Maximum degradation was predicted at a pH of 6.7, 70 A m(-2) and 45 min. The experimental data fitted well through a reduced quadratic model with R(2) equal to 0.945. The toxicity of degradation products as determined by disc diffusion assay employing Pseudomonas aeruginosa strain was found to be reduced by 55%. The degradation pathway of gentamicin was studied using mass spectral (MS) analysis. Pure gentamicin showed a molecular ion peak at m/z 478 ([M + 1](+)), and after addition of NaCl as electrolyte, the mass peak was observed at m/z 523. After 15 min of electrochemical treatment, a new peak appeared at m/z 316 due to the loss of one pyran moiety. After 45 min of electrochemical treatment, another peak appeared at m/z of 478 due to loss of two Na(+) from gentamicin.
Asunto(s)
Antibacterianos/aislamiento & purificación , Técnicas Electroquímicas , Gentamicinas/aislamiento & purificación , Análisis de Varianza , Antibacterianos/metabolismo , Antibacterianos/toxicidad , Gentamicinas/metabolismo , Gentamicinas/toxicidad , Pseudomonas aeruginosa/metabolismo , Espectrometría de Masa por Ionización de ElectrosprayRESUMEN
Pseudomonas aeruginosa es un microorganismo oportunista frecuentemente implicado en infecciones de origen nosocomial que presenta resistencia natural y adquirida a muchos de los antimicrobianos de uso clínico. Se llevo a cabo un estudio de resistencias a antimicrobianos de 3.029 aislamientos de P. aeruginosa de enfermos intra y extrahospitalarios en el periodo 2005-2010. La metodología utilizada fue, el método semiautomatizado WIDER I (Soria Melguizo), para la identificación de las especies y para el estudio de sensibilidades a antimicrobianos. Se consideraron los criterios de sensibilidad y resistencia recomendados por el grupo MENSURA. En nuestro hospital existe un mantenimiento relativo de la sensibilidad antimicrobiana de P. aeruginosa en el periodo 2005-2010, con un aumento de esta en amikacina, gentamicina y cefalosporinas. Existen diferencias de porcentajes de sensibilidades entre las cepas de origen intrahospitalario y extrahospitalario, salvo para fosfomicina y tobramicina. Destacamos la importancia de realizar estudios locales de la sensibilidad y resistencias de P. aeruginosa en cada zona, de forma periódica para poder valorar las diferentes pautas terapéuticas, no siendo posible extrapolar los datos de las diferentes regiones españolas(AU)
Pseudomonas aeruginosa is an opportunistic microorganism that is frequently the cause of nosocomial infections. Multiple mechanisms are involved in its natural and acquired resistance to many of the antimicrobial agents commonly used in clinical practice. We performed an antibiotic resistance study on P. aeruginosa isolated from intrahospitalary and extrahospitalary samples between 2005 and 2010 years. We included in the study a global amount of 3,029 P. aeruginosa isolates from clinical samples received at University Hospital Reina Sofia. Microbiology Service in Córdoba (Spain). Semiautomatic system WIDER I for strains identification and sensibility testing was employed. We considered susceptibility and resistance criteria recommended by MENSURA group. Results of the analysis showed that P. aeruginosa maintanied similar levels of antimicrobial susceptibility during the period 2005-2010, with increased susceptibility to amikacin, gentamicin and cefalosporins. There were also important differences in the degree of susceptibility between intrahospital and extrahospital strains during 2010 year, except for tobramicin and fosfomycin. The intrahospital difference in susceptibility was also evaluated, emphasizing the importance of periodically surveillance of susceptibility and resistance patterns of P. aeruginosa, in each setting in order to evaluate different therapeutic guidelines, because it is not always advisable to extrapolate data from different regions(AU)
Asunto(s)
Humanos , Masculino , Femenino , Pseudomonas aeruginosa , Antiinfecciosos/uso terapéutico , Tobramicina/uso terapéutico , Cefalosporinas/uso terapéutico , Piperacilina/aislamiento & purificación , Ceftazidima/aislamiento & purificación , Amicacina/aislamiento & purificación , Gentamicinas/aislamiento & purificación , Fosfomicina/aislamiento & purificación , Ciprofloxacina/aislamiento & purificación , Sensibilidad y Especificidad , Ticarcilina/aislamiento & purificación , Pseudomonas aeruginosa/aislamiento & purificación , Ticarcilina/farmacocinética , Piperacilina/farmacocinética , Ceftazidima/farmacocinética , Amicacina/farmacocinética , Gentamicinas/farmacocinética , Fosfomicina/farmacocinética , Ciprofloxacina/farmacocinéticaRESUMEN
We developed a useful and preparative method based on high-speed counter-current chromatography with mass spectrometry (HSCCC/MS) to purify gentamicin C1a, C2/2a and C1 from standard powder. The analytes were purified on the HSCCC model CCC-1000 (multi-layer coil planet centrifuge) with a volatile two-phase solvent system composed of n-butanol/10% aqueous ammonia solution (50:50, v/v) and detected on an LCMS-2020EV quadrupole mass spectrometer fitted with an electrospray ionization (ESI) source system in positive ionization following scan mode (m/z 100-500). The HSCCC/ESI-MS peaks indicated that gentamicin C1a (m/z 450: [M+H](+)), C2/2a (m/z 464: [M+H](+)) and C1 (m/z 478: [M+H](+)) have the peak resolution values of 1.3 and 1.7 from 30 mg of loaded gentamicin powder. The HSCCC yielded 3.9 mg of gentamicin C1a, 12.6 mg of gentamicin C2/2a and 12.0 mg of gentamicin C1. These purified substances were analyzed by LC/MS with scan positive-mode. Based on the LC/MS chromatograms and spectra of the fractions, analytes were estimated to be over 95% pure. These gentamicin isomers of C1a, C2/2a and C1 were evaluated for their antibacterial activities. The overall results indicate that this approach of HSCCC/MS is a powerful technique for the purification of gentamicin components.
Asunto(s)
Distribución en Contracorriente/métodos , Gentamicinas/aislamiento & purificación , Espectrometría de Masa por Ionización de Electrospray/métodos , Gentamicinas/química , IsomerismoRESUMEN
Liquid chromatography combined with pulsed electrochemical detection (LC-PED) is the method of choice in the European Pharmacopoeia for the determination of gentamicin and its related substances. A recently approved improved LC-PED method, with a reversed-phase C(18) column and a mobile phase consisting of trifluoroacetic acid (TFA), pentafluoropropionic acid (PFPA), sodium hydroxide and acetonitrile, showed better separation and more sensitive detection of the gentamicin components than the previous method using a polymer column. More unknown peaks can be separated from the main components and from each other. As the LC-PED method cannot be directly coupled to a mass spectrometer (MS), the unknown substances were collected after the LC column, desalted and analyzed by MS. The structures of the unknown compounds were deduced based on comparison of their fragmentation patterns with those of reference substances investigated by MS(n) experiments using an electrospray ion trap mass spectrometer. A comparison was also made with an already previously published LC-MS method using a volatile mobile phase.
Asunto(s)
Antibacterianos/análisis , Contaminación de Medicamentos , Gentamicinas/análisis , Farmacopeas como Asunto , Tecnología Farmacéutica , Antibacterianos/química , Antibacterianos/aislamiento & purificación , Cromatografía Líquida de Alta Presión , Técnicas Electroquímicas , Europa (Continente) , Fluorocarburos/química , Gentamicinas/química , Gentamicinas/aislamiento & purificación , Límite de Detección , Estructura Molecular , Solventes/química , Espectrometría de Masa por Ionización de Electrospray , Espectrometría de Masas en Tándem , Ácido Trifluoroacético/químicaRESUMEN
Gentamicin is an aminoglycoside antibiotic produced by various species of the genus Micromonospora and has received much attention in the recent years as a broad-spectrum antibiotic for treatment of various infections. It exists as a complex of closely related aminoglycoside structures and the clinically significant one is the gentamicin C complex. This review article focuses attention on the present status of knowledge and the main advancements achieved in the last few decades on the subject of gentamicin with regard to its production, biosynthetic pathway, mode of action, and uses. The various nutritional and environmental parameters affecting gentamicin production and the factors affecting the release of bound gentamicin are discussed. Further, strain improvement using UV and/or chemical mutagenesis can be applied to augment the efficiency of the producer strain and a number of case studies are presented. Different detection and quantitative methods for gentamicin estimation and the mode of action of gentamicin are discussed in detail. This antibiotic finds extensive use in combination chemotherapy and as a drug for different delivery agents for treatment of osteomyelitis and other recent applications in gene therapy.
Asunto(s)
Gentamicinas , Aminoglicósidos/biosíntesis , Aminoglicósidos/aislamiento & purificación , Aminoglicósidos/farmacología , Aminoglicósidos/uso terapéutico , Animales , Antibacterianos/biosíntesis , Antibacterianos/farmacología , Sistemas de Liberación de Medicamentos/tendencias , Quimioterapia Combinada , Mejoramiento Genético/métodos , Terapia Genética/tendencias , Gentamicinas/biosíntesis , Gentamicinas/aislamiento & purificación , Gentamicinas/farmacología , Gentamicinas/uso terapéutico , Humanos , Micromonospora/genética , Micromonospora/metabolismo , MutagénesisRESUMEN
Since the first use of streptomycin as an effective antibiotic drug in the treatment of tuberculosis, aminoglycoside antibiotics have been widely used against a variety of bacterial infections for over six decades. However, the pathways for aminoglycoside biosynthesis still remain unclear, mainly because of difficulty in genetic manipulation of actinomycetes producing this class of antibiotics. Gentamicin belongs to the group of 4,6-disubstituted aminoglycosides containing a characteristic core aminocyclitol moiety, 2-deoxystreptamine (2-DOS), and the recent discovery of its biosynthetic gene cluster in Micromonospora echinospora has enabled us to decipher its biosynthetic pathway. To determine the minimal set of genes and their functions for the generation of gentamicin A(2), the first pseudotrisaccharide intermediate in the biosynthetic pathway for the gentamicin complex, various sets of candidate genes from M. echinospora and other related aminoglycoside-producing strains were introduced into a nonaminoglycoside producing strain of Streptomyces venezuelae. Heterologous expression of different combinations of putative 2-DOS biosynthetic genes revealed that a subset, gtmB-gtmA-gacH, is responsible for the biosynthesis of this core aminocyclitol moiety of gentamicin. Expression of gtmG together with gtmB-gtmA-gacH led to production of 2'-N-acetylparomamine, demonstrating that GtmG acts as a glycosyltransferase that adds N-acetyl-d-glucosamine (GLcNA) to 2-DOS. Expression of gtmM in a 2'-N-acetylparomamine-producing recombinant S. venezuelae strain generated paromamine. Expression of gtmE in an engineered paromamine-producing strain of S. venezuelae successfully generated gentamicin A(2), indicating that GtmE is another glycosyltransferase that attaches d-xylose to paromamine. These results represent in vivo evidence elucidating the complete biosynthetic pathway of the pseudotrisaccharide aminoglycoside.
Asunto(s)
Expresión Génica , Genes Bacterianos , Gentamicinas/biosíntesis , Micromonospora/genética , Aminoglicósidos/biosíntesis , Aminoglicósidos/genética , Secuencia de Bases , Cromatografía Líquida de Alta Presión , Disacáridos/biosíntesis , Disacáridos/genética , Farmacorresistencia Bacteriana/genética , Gentamicinas/aislamiento & purificación , Hexosaminas/biosíntesis , Hexosaminas/genética , Datos de Secuencia Molecular , Familia de Multigenes , N-Acilesfingosina Galactosiltransferasa/genética , N-Acilesfingosina Galactosiltransferasa/metabolismo , Espectrometría de Masa por Ionización de Electrospray , Streptomyces/enzimología , Streptomyces/genéticaRESUMEN
Aminoglycoside antibiotics, although of major clinical importance in the treatment of serious Gram- negative infections and a potential therapeutic agent in the amelioration of diseases that are characterized by premature stop mutations, are associated with a high incidence of acute renal failure. With the use of HPLC techniques, the four components (congeners) of gentamicin, the most commonly used aminoglycoside, were isolated and characterized. Described here is a congener with minimal cytotoxicity in cell culture and animal studies that retained normal bactericidal properties in both Bacillus subtilis and a multidrug-resistant form of Klebsiella pneumoniae. Furthermore, in animal studies, this congener failed to induce the functional and pathologic changes that are characteristic of gentamicin nephrotoxicity that is seen with the native compound. Finally, internalization of this non-nephrotoxic component was unaltered, but the subcellular distribution was different from native gentamicin or the other three cytotoxic congeners. These studies have identified a component of the native gentamicin congener mixture that retains its bactericidal properties with minimal or no apparent nephrotoxicity.
Asunto(s)
Antibacterianos/farmacología , Bacillus subtilis/efectos de los fármacos , Gentamicinas/farmacología , Riñón/efectos de los fármacos , Klebsiella pneumoniae/efectos de los fármacos , Animales , Antibacterianos/química , Antibacterianos/aislamiento & purificación , Cromatografía Líquida de Alta Presión , Técnica del Anticuerpo Fluorescente Indirecta , Gentamicinas/química , Gentamicinas/aislamiento & purificación , Riñón/patología , Células LLC-PK1 , Masculino , Ratas , Ratas Sprague-Dawley , Fracciones SubcelularesRESUMEN
Antibiotics are routinely used for the decontamination of allograft heart valves. To monitor the efficacy of this process, samples of tissue are sent for microbiological analysis. This investigation was undertaken to determine residual antibiotic concentrations in decontaminated tissue and to assess the likely inhibitory effect on microbiological cultures. After a typical decontamination protocol, both gentamicin and vancomycin were present in all tissue samples and the majority of enrichment broths at concentrations sufficient to inhibit most bacteria. The data presented indicate that protocols used by heart valve banks and associated microbiology laboratories should be reviewed, and support the use of predecontamination cultures to identify particularly virulent micro-organisms.
Asunto(s)
Desinfección/métodos , Gentamicinas/aislamiento & purificación , Prótesis Valvulares Cardíacas , Vancomicina/aislamiento & purificación , Animales , Humanos , Porcinos , Trasplante HomólogoRESUMEN
We describe the development of a capillary electrophoresis method for the determination of gentamicin C1, C1a, C2a, and C2 components in human serum. Using a weak cation-exchanger with 20 mM phosphate buffer, pH 7.4, 200 mM borate buffer, pH 9.0, and ammonia/methanol, solid-phase extraction (SPE) of gentamicin components from the human sera was performed. The extract was derivatized with 1,2-phthalic dicarboxaldehyde/mercaptoacetic acid reagent. The derivatives were separated with a background electrolyte comprising 60 mM 2-(N-cyclohexylamino)ethanesulfonic acid (CHES) buffer at pH 9.5 containing 31.6% m/v methanol, and quantified with UV-light absorption detection at 230 nm. The identity of the gentamicin components was confirmed by mass spectrometry. The SPE recovery of the gentamicin ranged from 78% to 93%. The calibration curves were linear from the concentration limit of quantitation (LOQ) to 30 mg/L for the gentamicin mixture. The LOQ for gentamicin C1 was 0.33 mg/L, for C2a 0.23 mg/L, C2 0.25 mg/L, C1a 0.27 mg/L and the concentration limit of detection (LOD) for C1 was 0.15 mg/L, C2a 0.11 mg/L, C2 0.12 mg/L, C1a 0.13 mg/L. Intra-assay relative standard deviation (RSD) values were for C1 (5%), C1a (7%), C2 (6.5%) and C2a (9%); inter-assay RSD values were for C1 (11%), C1a (13.3%), C2 (15%) and C2a (14%). The Pearson's correlation between capillary electrophoresis and immunoassay revealed a linear relationship between these two techniques with r = 0.9. This method for determination of gentamicin C1, C1a, C2a, and C2 in human serum can thus be used in the entire therapeutic concentrations range of gentamicin.
Asunto(s)
Electroforesis Capilar/métodos , Gentamicinas/sangre , Gentamicinas/aislamiento & purificación , Gentamicinas/uso terapéutico , Humanos , Espectrometría de Masas , Reproducibilidad de los Resultados , o-Ftalaldehído/químicaRESUMEN
The present study was designed to yield results that would be used to contribute to the ongoing debate about the mechanism of the in vitro elution of an antibiotic from an antibiotic-loaded acrylic bone cement. To this end, the elution rates (R) of gentamicin sulfate (expressed as a weight percentage of the initial mass of the antibiotic in the specimen, normalized with respect to the duration of the test) from statically loaded (STATIC) and dynamically loaded (+/-10 MPa; 2 Hz; until fracture; DYNAMIC) specimens fabricated from a commercially available acrylic bone cement (VersaBond AB), in phosphate-buffered saline solution at 37 degrees C, were obtained with the use of a spectrophotometric method. There was evidence of microcracking in the fracture surfaces of DYNAMIC specimens, but no such evidence in the case of STATIC specimens. The surface area of the DYNAMIC specimens, during the tensile phase of the cyclical loading, was estimated to be about 3% larger than for the STATIC specimens (1742 mm(2) versus 1696 mm(2)). The bulk porosities P of the specimens in both sets were also determined and found to not be statistically different, with P for the STATIC and DYNAMIC specimens being 8.55 +/- 0.10 and 8.88 +/- 0.18%, respectively. At the end of the test period, R was found to be 0.36 +/- 0.20 and 1.28 +/- 0.14 wt %/day for the STATIC and DYNAMIC specimens, respectively. It is suggested that the present results provide support for the postulate that the elution mechanism of gentamicin in this cement is a surface phenomenon.
Asunto(s)
Cementos para Huesos/química , Gentamicinas/aislamiento & purificación , Polimetil Metacrilato , Ensayo de Materiales , Microscopía Electrónica de Rastreo , Análisis de RegresiónRESUMEN
Electro-chemical oxidation as a method to destroy drug residues like aspirin, tetracycline or gentamicine in water was investigated with C-anodes (modified by manganese oxides) and Pt anodes. The mechanism of aspirin and tetracycline oxidation and the influence of the biocide effect was observed using GC-MS and three different microbiological tests. In general, the biological availability increases with progressive oxidation of the antibiotics.
Asunto(s)
Antibacterianos/aislamiento & purificación , Antiinflamatorios no Esteroideos/aislamiento & purificación , Aspirina/aislamiento & purificación , Residuos de Medicamentos/aislamiento & purificación , Gentamicinas/aislamiento & purificación , Tetraciclina/aislamiento & purificación , Eliminación de Residuos Líquidos/métodos , Contaminantes del Agua/aislamiento & purificación , Purificación del Agua/métodos , Antibacterianos/química , Antiinflamatorios no Esteroideos/química , Aspirina/química , Electroquímica , Gentamicinas/química , Oxidación-Reducción , Tetraciclina/químicaRESUMEN
A simple method for the separation of the major components of commercial gentamicin sulfate (C-1, C-1a, C-2, C-2a) by high-performance liquid chromatography (HPLC) on an analytical and a semipreparative scale was developed. The method utilized ion-pair reversed-phase chromatography, isocratic elution with an aqueous solution containing 9% trifluoroacetic acid and 2.5% acetonitrile as the mobile phase at a flow rate of 2 and 9 mL/min for analytical and semipreparative columns, respectively. Detection was carried out at 213 nm without derivatization. The protonation pattern of the separated gentamicins was determined by potentiometry and 15N and 1H NMR. The full proton NMR assignment for gentamicin C-1 was obtained through the use of 1H 1D and 2D 1H-1H COSY measurements.